Pharmatjek Nordic ApS: Financial statements 2023
CVR: 42791776
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharmatjek Nordic ApS (CVR 42791776) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 669,623 and a net result of DKK 62,573. Equity in the 2023 report amounted to DKK 32,828. The solvency ratio was 24.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 669,623
- Profit/Loss
- DKK 62,573
- Equity
- DKK 32,828
- Total Assets
- DKK 132,821
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharmatjek Nordic ApS has published its interim report for the period October 27, 2021 to December 31, 2022.
About Pharmatjek Nordic ApS
Pharmatjek Nordic ApS was a Danish company of the type Anpartsselskab based in Slagelse, founded in 2021. The company has been dissolved on 18 August 2026. The company was registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company has 4 employees (2025). In 2024, the company reported a gross profit of DKK 1,413,302 and a net result of DKK -131,310 compared with DKK 62,573 the year before. Equity in the 2024 report amounted to DKK -98,482.
